NantOmics
Precision medicine through comprehensive molecular profiling
San Francisco, United States · Founded 2013 · $100.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- nantomics.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Venture RoundJan 2016
- Rounds
- 1
About
NantOmics, founded in 2013 by Patrick Soon-Shiong and part of the NantWorks ecosystem, is a leader in molecular diagnostic testing based in Culver City, California. The company was the first to employ an integrated panomic approach to inform personalized treatment options for cancer patients. Its platform combines whole genome DNA sequencing, RNA sequencing, and quantitative proteomics, delivering actionable molecular profiles matched to targeted therapies. NantOmics' knowledge database spans hundreds of oncogenes and thousands of cellular pathways.
Summary
NantOmics is a Biotech company based in San Francisco, United States, founded in 2013. It has raised $100.0M in total across 1 round, most recently a $100.0M Venture Round round in Jan 2016. Investors include NantWorks.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2016
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company